Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Yu. A. Starchina"'
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 4, Pp 85-89 (2024)
In elderly patients, vestibular disorders are often associated with concomitant diseases and lead to falls and injuries. When treating elderly patients, it is necessary to determine an underlying cause of dizziness, and assess concomitant diseases, m
Externí odkaz:
https://doaj.org/article/7f077dd07a554a319b428c245f51d4d1
Autor:
K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 3, Pp 96-102 (2024)
Diagnostic hypothesis of Alzheimer's disease (AD) is based on the typical clinical picture of the disease and the exclusion of other diseases manifesting by cognitive and behavioural disorders by MRI scans of the brain and laboratory tests. For an ac
Externí odkaz:
https://doaj.org/article/e2c829d74d8040be9b16c28d1cf68c80
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 6, Pp 64-70 (2023)
Mild cognitive impairment (MCI) is an intermediate stage between normal cognitive function (CF) and dementia. In the general population of elderly, it is diagnosed in 10–15% of cases; in patients attending outpatient appointments, the frequency of
Externí odkaz:
https://doaj.org/article/5d1bcbbb98674de2a3623bf8bd7297d3
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 2, Pp 91-97 (2023)
Cerebrovascular disease is one of the most common pathologies in the practice of a neurologist. Vascular cognitive impairment is the earliest and most objective sign of cerebrovascular pathology. The correction of vascular risk factors – antihypert
Externí odkaz:
https://doaj.org/article/988a0960192842039d0e43dd30e073bc
Autor:
Yu. A. Starchina, K. S. Sleptcova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 5, Pp 90-95 (2021)
Cognitive impairment (CI) is one of the earliest and most frequent neurological disorders in patients with arterial hypertension. Arterial hypertension is a leading modifiable risk factor for stroke and cerebral microangiopathy, which underlies the d
Externí odkaz:
https://doaj.org/article/be92c8231fa844689d075154b474b9b9
Autor:
Yu. A. Starchina, V. V. Zakharov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 3, Pp 119-124 (2021)
With an increase in life expectancy in the population, the proportion of people with cognitive impairment (CI) increases. Modern neurology focuses on the milder forms of CI: moderate, mild, and subjective CI, which are more promising in terms of succ
Externí odkaz:
https://doaj.org/article/7dcb32b339284ead8b966cecbd8049f5
Autor:
Yu. A. Starchina, V. V. Zakharov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 1, Pp 113-118 (2021)
As the life expectancy of the population increases, cognitive impairment (CI) caused by cerebrovascular diseases is becoming an increasingly urgent problem. The leading role of hypertension in the development of CI of various origins has led to inten
Externí odkaz:
https://doaj.org/article/fa715cbac6344b96a475536113d2df9c
Autor:
Yu. A. Starchina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 3S, Pp 89-94 (2019)
Secondary prevention of recurrent stroke and other cardiovascular diseases is of key importance for the management of a patient after ischemic stroke. Medications (antihypertensive, antiplatelet, or anticoagulant drugs and statins) are recommended fo
Externí odkaz:
https://doaj.org/article/84e1568bca804205bd677b5710c02dc3
Autor:
Yu. A. Starchina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 9, Iss 2, Pp 71-76 (2017)
In recent decades, special attention is given to cognitive impairments (CIs) without dementia, which include moderate (MCI), mild, and subjective ones. Epidemiological studies suggest that the prevalence of CI is high in elderly people (10–15%) and
Externí odkaz:
https://doaj.org/article/9b027e5e73194ade969735447002bef1
Autor:
Yu. A. Starchina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 3, Iss 2, Pp 81-85 (2011)
The paper gives the data of studies of the efficacy of choline alphoscerate in neurological care. It analyzes the possibilities of using cereton (choline alphoscerate) made in Russia to treat cerebrovascular diseases and cognitive disorders of differ
Externí odkaz:
https://doaj.org/article/ec4f2b63889b43a89471dd60b9e500be